Financials
- Market Capitalization 12.28 M
- Employee 97
- Founded 2003
- CEO Erik Holmlin
- Website www.bionano.com
- Headquarter Delaware, United States
- FIGI BBG001KWWRS9
- Industry Medical Instruments & Supplies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4570 | RVP Retractable Technologies, Inc. Common Stock | 0.66 USD | -2.94% | -2.94% | -9.59% | -4.43% | 19.76 M USD | ||
| 4634 | ZJYL JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares | 2.06 USD | +7.85% | +3.00% | +7.85% | +216.92% | 16.12 M USD | ||
| 4797 | FEMY Femasys Inc. - Common Stock | 2.86 USD | -1.72% | -20.56% | -34.40% | +271.43% | 8.64 M USD | ||
| 4844 | MLSS Milestone Scientific, Inc. Common Stock | 0.40 USD | +2.56% | +2.56% | +21.21% | -34.43% | 7.05 M USD |
Frequently asked questions about Bionano Genomics, Inc. - Common Stock
What is the Bionano Genomics, Inc. - Common Stock stock price today?
The current price of Bionano Genomics, Inc. - Common Stock (BNGO) is 1.07. Over the past 24 hours, the stock has changed by +0.94%. Follow the BNGO chart for real-time price dynamics.
What is the stock ticker of Bionano Genomics, Inc. - Common Stock?
Bionano Genomics, Inc. - Common Stock trades under the ticker BNGO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bionano Genomics, Inc. - Common Stock stock going up?
BNGO has changed by -4.46% over the last week, -8.55% over the last month, and -6.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bionano Genomics, Inc. - Common Stock?
Bionano Genomics, Inc. - Common Stock currently has a market capitalization of 12.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Bionano Genomics, Inc. - Common Stock earnings last quarter?
Last quarter, Bionano Genomics, Inc. - Common Stock reported earnings of -0.76 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Bionano Genomics, Inc. - Common Stock revenue for the last quarter?
Bionano Genomics, Inc. - Common Stock reported quarterly revenue of 6.69 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Bionano Genomics, Inc. - Common Stock net income for the last quarter?
Bionano Genomics, Inc. - Common Stock reported net income of -8.3 M for the last quarter. The previous quarter showed -7.93 M, which means net income changed by -4.66%.
How many employees does Bionano Genomics, Inc. - Common Stock have?
As of the latest available data, Bionano Genomics, Inc. - Common Stock has 97 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bionano Genomics, Inc. - Common Stock EBITDA?
Bionano Genomics, Inc. - Common Stock EBITDA is -2.15 M, and its EBITDA margin is -32.18%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bionano Genomics, Inc. - Common Stock stock?
You can buy Bionano Genomics, Inc. - Common Stock (BNGO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bionano Genomics, Inc. - Common Stock stock?
Investing in Bionano Genomics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BNGO chart and related analysis on metatrader.com as part of your research.